Award
National Cancer Institute 5R01CA272771-04
The role of USP27X-Cyclin D1 axis in HER2 Therapy Resistant Breast Cancer
Recipient
National Cancer Institute (NCI), part of the NIH
Award Amount
$468,436.00
Ceiling
$468,436.00
Awarded
February 27, 2026
Identifier
5R01CA272771-04
NIH awarded a grant to study the role of USP27X-Cyclin D1 axis in HER2 therapy-resistant breast cancer, aiming to understand CCND1 regulation and explore USP27X as a therapeutic target.
Description
This is a NIH grant project focusing on the role of USP27X in HER2 therapy-resistant breast cancer, with a focus on CCND1 regulation and potential therapeutic targeting of USP27X.